Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort.

Le LAK, Johannessen A, Hardie JA, Johansen OE, Gulsvik A, Vikse BE, Bakke P.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 23;14:1639-1655. doi: 10.2147/COPD.S194019. eCollection 2019.

2.

Lung hyperinflation and functional exercise capacity in patients with COPD - a three-year longitudinal study.

Aalstad LT, Hardie JA, Espehaug B, Thorsen E, Bakke PS, Eagan TML, Frisk B.

BMC Pulm Med. 2018 Dec 6;18(1):187. doi: 10.1186/s12890-018-0747-9.

3.

Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients.

Conrad DJ, Bailey BA, Hardie JA, Bakke PS, Eagan TML, Aarli BB.

PLoS One. 2017 Dec 20;12(12):e0190061. doi: 10.1371/journal.pone.0190061. eCollection 2017.

4.

The association of tidal EFL with exercise performance, exacerbations, and death in COPD.

Aarli BB, Calverley PM, Jensen RL, Dellacà R, Eagan TM, Bakke PS, Hardie JA.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 26;12:2179-2188. doi: 10.2147/COPD.S138720. eCollection 2017.

5.

Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.

Persson LJ, Aanerud M, Hardie JA, Miodini Nilsen R, Bakke PS, Eagan TM, Hiemstra PS.

Eur Respir J. 2017 Mar 15;49(3). pii: 1601328. doi: 10.1183/13993003.01328-2016. Print 2017 Mar.

6.

Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.

Husebø GR, Grønseth R, Lerner L, Gyuris J, Hardie JA, Bakke PS, Eagan TM.

Eur Respir J. 2017 Mar 15;49(3). pii: 1601298. doi: 10.1183/13993003.01298-2016. Print 2017 Mar.

7.

Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients.

Eagan TM, Hardie JA, Jul-Larsen Å, Grydeland TB, Bakke PS, Cox RJ.

Respir Med. 2016 Jun;115:53-9. doi: 10.1016/j.rmed.2016.04.008. Epub 2016 Apr 20.

8.

Macrophage migration inhibitory factor, a role in COPD.

Husebø GR, Bakke PS, Grønseth R, Hardie JA, Ueland T, Aukrust P, Eagan TM.

Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L1-7. doi: 10.1152/ajplung.00461.2015. Epub 2016 May 17.

9.

Diffusion capacity and CT measures of emphysema and airway wall thickness - relation to arterial oxygen tension in COPD patients.

Saure EW, Bakke PS, Lind Eagan TM, Aanerud M, Jensen RL, Grydeland TB, Johannessen A, Nilsen RM, Thorsen E, Hardie JA.

Eur Clin Respir J. 2016 May 12;3:29141. doi: 10.3402/ecrj.v3.29141. eCollection 2016.

10.

Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD.

Waatevik M, Johannessen A, Gomez Real F, Aanerud M, Hardie JA, Bakke PS, Lind Eagan TM.

Eur Respir J. 2016 Jul;48(1):82-91. doi: 10.1183/13993003.00975-2015. Epub 2016 Apr 13.

11.

Peak oxygen uptake and breathing pattern in COPD patients--a four-year longitudinal study.

Frisk B, Hardie JA, Espehaug B, Strand LI, Moe-Nilssen R, Eagan TM, Bakke PS, Thorsen E.

BMC Pulm Med. 2015 Aug 19;15:93. doi: 10.1186/s12890-015-0095-y.

12.

Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD.

Persson LJ, Aanerud M, Hiemstra PS, Michelsen AE, Ueland T, Hardie JA, Aukrust P, Bakke PS, Eagan TM.

PLoS One. 2015 Mar 24;10(3):e0121622. doi: 10.1371/journal.pone.0121622. eCollection 2015.

13.

Zopiclone effects on breathing at sleep in stable chronic obstructive pulmonary disease.

Holmedahl NH, Øverland B, Fondenes O, Ellingsen I, Hardie JA.

Sleep Breath. 2015 Sep;19(3):921-30. doi: 10.1007/s11325-014-1084-8. Epub 2014 Dec 13.

PMID:
25501294
14.

Variability of within-breath reactance in COPD patients and its association with dyspnoea.

Aarli BB, Calverley PM, Jensen RL, Eagan TM, Bakke PS, Hardie JA.

Eur Respir J. 2015 Mar;45(3):625-34. doi: 10.1183/09031936.00051214. Epub 2014 Oct 30. Erratum in: Eur Respir J. 2017 Jan 25;49(1):.

15.

Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.

Husebø GR, Bakke PS, Aanerud M, Hardie JA, Ueland T, Grønseth R, Persson LJ, Aukrust P, Eagan TM.

PLoS One. 2014 Oct 3;9(10):e109721. doi: 10.1371/journal.pone.0109721. eCollection 2014.

16.

Serial Measurements of Arterial Oxygen Tension are Associated with Mortality in COPD.

Aanerud M, Saure EW, Benet M, Basagana X, Bakke PS, Garcia-Aymerich J, Eagan TM, Anto JM, Hardie JA.

COPD. 2015 Jun;12(3):287-94. doi: 10.3109/15412555.2014.948996. Epub 2014 Sep 17.

PMID:
25230156
17.

Alcohol at bedtime induces minor changes in sleep stages and blood gases in stable chronic obstructive pulmonary disease.

Holmedahl NH, Øverland B, Fondenes O, Ellingsen I, Hardie JA.

Sleep Breath. 2015 Mar;19(1):307-14. doi: 10.1007/s11325-014-1020-y. Epub 2014 Jun 17.

18.

Predictors for PaO2 and hypoxemic respiratory failure in COPD-A three-year follow-up.

Saure EW, Eagan TM, Jensen RL, Bakke PS, Johannessen A, Aanerud M, Nilsen RM, Thorsen E, Hardie JA.

COPD. 2014 Sep;11(5):531-8. doi: 10.3109/15412555.2014.898027. Epub 2014 May 15.

PMID:
24831555
19.

Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients.

Frisk B, Espehaug B, Hardie JA, Strand LI, Moe-Nilssen R, Eagan TM, Bakke PS, Thorsen E.

Physiol Rep. 2014 Feb 7;2(2):e00222. doi: 10.1002/phy2.222. eCollection 2014 Feb 1.

20.

Sleep hypoventilation and daytime hypercapnia in stable chronic obstructive pulmonary disease.

Holmedahl NH, Øverland B, Fondenes O, Ellingsen I, Hardie JA.

Int J Chron Obstruct Pulmon Dis. 2014 Feb 27;9:265-75. doi: 10.2147/COPD.S57576. eCollection 2014.

21.

Predictors of dyspnoea prevalence: results from the BOLD study.

Grønseth R, Vollmer WM, Hardie JA, Ólafsdóttir IS, Lamprecht B, Buist AS, Gnatiuc L, Gulsvik A, Johannessen A, Enright P.

Eur Respir J. 2014 Jun;43(6):1610-20. doi: 10.1183/09031936.00036813. Epub 2013 Oct 31.

22.

Physical activity and longitudinal change in 6-min walk distance in COPD patients.

Frisk B, Espehaug B, Hardie JA, Strand LI, Moe-Nilssen R, Eagan TM, Bakke PS, Thorsen E.

Respir Med. 2014 Jan;108(1):86-94. doi: 10.1016/j.rmed.2013.09.004. Epub 2013 Sep 13.

23.

FVC, total lung capacity, and the differential association to mortality.

Hardie JA.

Chest. 2012 Nov;142(5):1354. doi: 10.1378/chest.12-1642. No abstract available.

PMID:
23131950
24.

Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly.

Aarli BB, Eagan TM, Ellingsen I, Bakke PS, Hardie JA.

Clin Respir J. 2013 Jul;7(3):245-52. doi: 10.1111/j.1752-699X.2012.00312.x. Epub 2012 Aug 20.

PMID:
22822726
25.

Chronic obstructive pulmonary disease is associated with low levels of vitamin D.

Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TM.

PLoS One. 2012;7(6):e38934. doi: 10.1371/journal.pone.0038934. Epub 2012 Jun 21.

26.

TNF-α is associated with loss of lean body mass only in already cachectic COPD patients.

Eagan TM, Gabazza EC, D'Alessandro-Gabazza C, Gil-Bernabe P, Aoki S, Hardie JA, Bakke PS, Wagner PD.

Respir Res. 2012 Jun 18;13:48. doi: 10.1186/1465-9921-13-48.

27.

Different COPD disease characteristics are related to different outcomes in the 6-minute walk test.

Waatevik M, Johannessen A, Hardie JA, Bjordal JM, Aukrust P, Bakke PS, Eagan TM.

COPD. 2012 Jun;9(3):227-34. doi: 10.3109/15412555.2011.650240. Epub 2012 Apr 12.

PMID:
22497532
28.

Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults.

Johannessen A, Bakke PS, Hardie JA, Eagan TM.

Respirology. 2012 Apr;17(3):499-505. doi: 10.1111/j.1440-1843.2012.02129.x.

PMID:
22248329
29.

The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway.

Gjerde B, Bakke PS, Ueland T, Hardie JA, Eagan TM.

Respir Med. 2012 Mar;106(3):361-6. doi: 10.1016/j.rmed.2011.10.004. Epub 2011 Nov 29.

30.

Explained variance for blood gases in a population with COPD.

Saure EW, Eagan TM, Jensen RL, Voll-Aanerud M, Aukrust P, Bakke PS, Hardie JA.

Clin Respir J. 2012 Apr;6(2):72-80. doi: 10.1111/j.1752-699X.2011.00248.x. Epub 2011 Aug 3.

PMID:
21812941
31.

A randomised trial of endobronchial ultrasound guided sampling in peripheral lung lesions.

Roth K, Eagan TM, Andreassen AH, Leh F, Hardie JA.

Lung Cancer. 2011 Nov;74(2):219-25. doi: 10.1016/j.lungcan.2011.02.013. Epub 2011 Apr 11.

PMID:
21481486
32.

High prevalence of respiratory symptoms during air travel in patients with COPD.

Edvardsen A, Akerø A, Hardie JA, Ryg M, Eagan TM, Skjønsberg OH, Bakke PS.

Respir Med. 2011 Jan;105(1):50-6. doi: 10.1016/j.rmed.2010.10.006. Epub 2010 Oct 25.

33.

Neutrophil gelatinase-associated lipocalin: a biomarker in COPD.

Eagan TM, Damås JK, Ueland T, Voll-Aanerud M, Mollnes TE, Hardie JA, Bakke PS, Aukrust P.

Chest. 2010 Oct;138(4):888-95. doi: 10.1378/chest.09-2718. Epub 2010 May 21.

PMID:
20495108
34.

Body composition and plasma levels of inflammatory biomarkers in COPD.

Eagan TM, Aukrust P, Ueland T, Hardie JA, Johannessen A, Mollnes TE, Damås JK, Bakke PS, Wagner PD.

Eur Respir J. 2010 Nov;36(5):1027-33. doi: 10.1183/09031936.00194209. Epub 2010 Apr 22.

35.

Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease.

Eagan TM, Aukrust P, Bakke PS, Damås JK, Skorge TD, Hardie JA, Ueland T, Mollnes TE.

Respir Med. 2010 Feb;104(2):283-90. doi: 10.1016/j.rmed.2009.09.015.

36.

Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study.

Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, Aukrust P, Bakke PS.

Eur Respir J. 2010 Mar;35(3):540-8. doi: 10.1183/09031936.00088209. Epub 2009 Jul 30.

37.

Cost minimization analysis for combinations of sampling techniques in bronchoscopy of endobronchial lesions.

Roth K, Hardie JA, Andreassen AH, Leh F, Eagan TM.

Respir Med. 2009 Jun;103(6):888-94. doi: 10.1016/j.rmed.2008.12.012.

38.

Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques.

Roth K, Hardie JA, Andreassen AH, Leh F, Eagan TM.

BMC Pulm Med. 2008 Jan 26;8:2. doi: 10.1186/1471-2466-8-2.

39.

Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years.

Hardie JA, Vollmer WM, Buist AS, Bakke P, Mørkve O.

Respir Med. 2005 Feb;99(2):186-95.

40.

Reference values for arterial blood gases in the elderly.

Hardie JA, Vollmer WM, Buist AS, Ellingsen I, Mørkve O.

Chest. 2004 Jun;125(6):2053-60.

PMID:
15189921
41.

Non-response bias in a postal questionnaire survey on respiratory health in the old and very old.

Hardie JA, Bakke PS, Mørkve O.

Scand J Public Health. 2003;31(6):411-7.

PMID:
14675932
42.

Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.

Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Mørkve O.

Eur Respir J. 2002 Nov;20(5):1117-22.

43.

Effect of body position on arterial oxygen tension in the elderly.

Hardie JA, Mørkve O, Ellingsen I.

Respiration. 2002;69(2):123-8.

PMID:
11961425
45.

The origin of pulmonary alveolar macrophages. Studies of stem cells using the Es-2 marker of mice.

Brunstetter MA, Hardie JA, Schiff R, Lewis JP, Cross CE.

Arch Intern Med. 1971 Jun;127(6):1064-8. No abstract available.

PMID:
5578563
46.

Pulmonary alveolar macrophage. Membrane associated sodium ion, potassium ion, and magnesium ion adenosine triphosphatase system.

Cross CE, Mustafa MG, Peterson P, Hardie JA.

Arch Intern Med. 1971 Jun;127(6):1069-77. No abstract available.

PMID:
4252861
47.

Effects of divalent metal ions on alveolar macrophage membrane adenosine triphosphatase activity.

Mustafa MG, Cross CE, Munn RJ, Hardie JA.

J Lab Clin Med. 1971 Apr;77(4):563-71. No abstract available.

PMID:
4252000
48.

Localization of Na plus-K +,MG ++ adenosinetriphosphatase activity in pulmonary alveolar macrophage subcellular fractions.

Mustafa MG, Cross CE, Hardie JA.

Life Sci I. 1970 Aug 15;9(16):947-54. No abstract available.

PMID:
4249840

Supplemental Content

Loading ...
Support Center